Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. POLYMERASE CHAIN REACTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 INSTALLATION BASE
4.4 COST ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 HEALTHCARE ECONOMY
4.6.1 HEALTHCARE EXPENDITURE
4.6.2 CAPITAL EXPENDITURE
4.6.3 CAPEX TRENDS
4.6.4 CAPEX ALLOCATIONS
4.6.5 FUNDING SOURCES
4.6.6 INDUSTRY BENCHMARKS
4.6.7 GDP RATIO IN OVERALL GDP
4.6.8 HEALTHCARE SYSTEM STRUCTURE
4.6.9 GOVERNMENT POLICIES
4.6.10 ECONOMIC DEVELOPMENT
4.7 INDUSTRY INSIGHTS
4.7.1 MICRO AND MACROECONOMIC FACTORS
4.7.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.7.3 KEY PRICING STRATEGIES
4.8 TECHNOLOGY ROADMAP
5 REGULATORY COMPLIANCE
5.1 REGULATORY AUTHORITIES
5.2 REGULATORY CLASSIFICATIONS
5.3 REGULATORY SUBMISSIONS
5.4 INTERNATIONAL HARMONIZATION
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO
5.6 REGULATORY CHALLENGES AND STRATEGY
6 MARKET OVERVIEW, U.S. POLYMERASE CHAIN REACTION MARKET
6.1 DRIVERS
6.1.1 RISE IN THE AVAILABILITY OF PCR DIAGNOSTICS
6.1.2 INCREASING APPLICATION OF PCR
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE
6.2 RESTRAINTS
6.2.1 LIMITATIONS WHILE ANALYZING THE NOVEL COMPLEX DEVICE
6.2.2 LONG APPROVAL PROCEDURE
6.3 OPPORTUNITIES
6.3.1 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 INCREASE IN THE PRODUCT RECALLS
6.4.2 HIGH COST OF PCR MEDICAL DEVICE DEVELOPMENT
7 U.S. POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 REAGENTS
7.2.1 DNA OR PCR TEMPLATES
7.2.2 DNA POLYMERASE I ENZYME
7.2.2.1 TAQ DNA POLYMERASE
7.2.2.2 HIGH-FIDELITY DNA POLYMERASE
7.2.2.3 GREEN TAQ DNA POLYMERASE
7.2.2.4 HOT START TAQ DNA POLYMERASE
7.2.2.5 PROOFREADING DNA POLYMERASE
7.2.2.6 OTHERS
7.2.3 PRIMERS
7.2.4 DEOXYNUCLEOTIDE TRIPHOSPHATES (DNTPS)
7.2.5 PCR BUFFERS
7.2.5.1 TRIS-HCL
7.2.5.2 POTASSIUM CHLORIDE (KCL)
7.2.5.3 MAGNESIUM CHLORIDE
7.2.6 MASTER MIX OR PCR KIT
7.2.7 PROBES
7.2.8 ANTI-TAQ DNA POLYMERASE ANTIBODY
7.2.9 DIGITAL PCR SUPERMIXES
7.2.10 OTHERS
7.3 INSTRUMENTS
7.3.1 BY TYPE
7.3.1.1 DIGITAL PCR
7.3.1.1.1 DIGITAL PCR(DDPCR)
7.3.1.1.2 CHIP BASED DIGITAL PCR
7.3.1.1.3 BEAMING DIGITAL PCR
7.3.1.2 REAL TIME PCR
7.3.1.3 CONVENTIONAL PCR
7.3.1.4 OTHERS
7.3.2 BY MODALITY
7.3.2.1 STANDLONE
7.3.2.2 HANDHELD
7.3.2.3 PORTABLE
7.4 CONSUMABLES
7.4.1 PCR TUBES AND CAPS
7.4.2 PCR STRIPS
7.4.3 PCR WELL PLATES
7.4.4 STRIP TUBES
7.4.5 PLATE SEALS
7.4.6 CARTRIDGES AND GASKETS
7.4.7 OTHERS
7.5 SOFTWARE AND SERVICES
8 U.S. POLYMERASE CHAIN REACTION MARKET, BY METHOD
8.1 OVERVIEW
8.2 REAL-TIME PCR
8.3 REVERSE-TRANSCRIPTASE(RT) PCR
8.4 CONVENTIONAL PCR
8.5 MULTIPLEX PCR
8.6 NESTED PCR
8.7 HOT START PCR
8.8 LONG-RANGE PCR
8.9 ASSEMBLY PCR
8.1 INVERSE PCR
8.11 OTHERS
9 U.S. POLYMERASE CHAIN REACTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL
9.2.1 ONCOLOGY TESTING
9.2.2 INFECTIOUS DISEASE TESTING
9.2.2.1 HUMAN PAPILLOMAVIRUS
9.2.2.2 HIV
9.2.2.3 HCV
9.2.2.4 HEPATITIS B VIRUS
9.2.2.5 OTHERS
9.2.3 TRANSPLANT DIAGNOSTICS
9.2.4 PATERNITY TESTING
9.2.5 OTHERS
9.3 LIFE SCIENCE AND RELATED RESEARCHES
9.3.1 MICROBIOLOGY
9.3.2 MOLECULAR AND CELL BIOLOGY
9.3.3 OTHERS
9.4 FORENSIC SCIENCE
9.4.1 DNA TYPING
9.4.2 DNA TESTING
9.4.3 GENETIC FINGERPRINTING
9.5 ENVIRONMENTAL MICROBIOLOGY
9.5.1 DETECTION OF TARGETED MICROORGANISMS
9.5.2 QUANTIFICATION OF MICROBIAL POPULATION
9.5.3 MICROBIAL COMMUNITY ANALYSIS
9.5.4 DETECTION OF MICROBIAL PATHOGEN
9.5.5 DETECTION OF GENE EXPRESSION IN THE ENVIRONMENT
9.5.6 DETECTION OF INDICTOR MICROORGANISMS IN WATER
9.5.7 ENVIRONMENTAL DNA ANALYSIS
9.5.8 OTHERS
9.6 OTHERS
10 U.S. POLYMERASE CHAIN REACTION MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3 HOSPITALS AND CLINICS
10.3.1 PRIVATE
10.3.1.1 TIER 1
10.3.1.2 TIER 2
10.3.1.3 TIER 3
10.3.2 PUBLIC
10.3.2.1 TIER 1
10.3.2.2 TIER 2
10.3.2.3 TIER 3
10.4 DIAGNOSTIC LABORATORIES
10.5 ACADEMIC AND RESEARCH ORGANIZATIONS
10.6 FORENSIC LABORATORIES
10.7 REFERENCE LABORATORIES
10.8 OTHERS
11 U.S. POLYMERASE CHAIN REACTION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 OTHERS
12 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: U.S.
13 SWOT ANALYSIS
14 U.S. POLYMERASE CHAIN REACTION MARKET, COMPANY PROFILE
14.1 MERCK KGAA
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 F. HOFFMANN- LA ROCHE LTD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 BIO-RAD LABORATORIES, INC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 QIAGEN
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 AGILENT TECHNOLOGIES, INC.
14.5.1 COMPANY PROFILE
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 ABBOTT
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 BECKMAN COULTER, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 BIOMERIUX
14.8.1 COMPANY PROFILE
14.8.2 REVENUE ANALYSIS
14.8.4 RECENT DEVELOPMENT
14.9 ENZO LIFE SCIENCES, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 GENSCRIPT
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 ILLUMINA INC
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.12 LGC BIOSEARCH TECHNOLOGIES
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 LUMINEX CORPORATION
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 MERIDIAN BIOSCIENCE INC
14.14.1 COMPANY PROFILE
14.14.2 REVENUE ANALYSIS
14.14.4 RECENT DEVELOPMENT
14.15 PERKINELMER INC
14.15.1 COMPANY PROFILE
14.15.2 REVENUE ANALYSIS
14.15.4 RECENT DEVELOPMENT
14.16 PROMEGA CORPORATION
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 TAKARA BIO INC
14.17.1 COMPANY PROFILE
14.17.2 REVENUE ANALYSIS
14.17.4 RECENT DEVELOPMENT
14.18 THERMO FISHER SCIENTIFIC
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 U.S. POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 U.S. REAGENTS IN POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 3 U.S. DNA POLYMERASE I ENZYME IN POLYMERASE CHAIN REACTION MARKET, BY REAGENTS, 2021-2030 (USD MILLION)
TABLE 4 U.S. PCR BUFFERS IN POLYMERASE CHAIN REACTION MARKET, BY REAGENTS, 2021-2030 (USD MILLION)
TABLE 5 U.S. INSTRUMENTS IN POLYMERASE CHAIN REACTION MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 U.S. DIGITAL PCR IN POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 7 U.S. INSTRUMENTS IN POLYMERASE CHAIN REACTION MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 U.S. CONSUMABLES IN POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 U.S. POLYMERASE CHAIN REACTION MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 10 U.S. POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 11 U.S. CLINICAL IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 U.S. INFECTIOUS DISEASE TESTING IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 U.S. LIFE SCIENCE AND RELATED RESEARCHES IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 U.S. FORENSIC SCIENCE IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 15 U.S. ENVIRONMENTAL MICROBIOLOGY IN POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 U.S. POLYMERASE CHAIN REACTION MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 17 U.S. HOSPITALS AND CLINICS IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 18 U.S. PRIVATE IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 19 U.S. PUBLIC IN POLYMERASE CHAIN REACTION MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 20 U.S. POLYMERASE CHAIN REACTION MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
List of Figure
FIGURE 1 U.S. POLYMERASE CHAIN REACTION MARKET: SEGMENTATION
FIGURE 2 U.S. POLYMERASE CHAIN REACTION MARKET: DATA TRIANGULATION
FIGURE 3 U.S. POLYMERASE CHAIN REACTION MARKET: DROC ANALYSIS
FIGURE 4 U.S. POLYMERASE CHAIN REACTION MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. POLYMERASE CHAIN REACTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. POLYMERASE CHAIN REACTION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. POLYMERASE CHAIN REACTION MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 U.S. POLYMERASE CHAIN REACTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 U.S. POLYMERASE CHAIN REACTION MARKET: SEGMENTATION
FIGURE 11 INCREASING APPLICATION OF PCR IS EXPECTED TO DRIVE THE GROWTH OF THE U.S. POLYMERASE CHAIN REACTION MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. POLYMERASE CHAIN REACTION MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE U.S. POLYMERASE CHAIN REACTION MARKET
FIGURE 14 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 U.S. POLYMERASE CHAIN REACTION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, 2022
FIGURE 19 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 20 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 21 U.S. POLYMERASE CHAIN REACTION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 22 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, 2022
FIGURE 23 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 U.S. POLYMERASE CHAIN REACTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, 2022
FIGURE 27 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 U.S. POLYMERASE CHAIN REACTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 U.S. POLYMERASE CHAIN REACTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 U.S. POLYMERASE CHAIN REACTION MARKET: COMPANY SHARE 2022 (%)
